Cellebrite DI Ltd.
CLBT
$14.44
-$0.09-0.62%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 21.26M | 19.48M | 19.27M | -207.09M | |
| Total Depreciation and Amortization | 3.94M | 2.59M | 2.73M | 2.62M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 14.31M | 3.92M | 3.75M | 234.44M | |
| Change in Net Operating Assets | 47.30M | 6.60M | 40.22M | 11.68M | |
| Cash from Operations | 86.81M | 32.58M | 65.97M | 41.65M | |
| Capital Expenditure | -3.96M | -3.61M | -3.18M | -1.82M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -147.46M | -- | 0.00 | -2.75M | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -94.70M | 44.19M | -12.77M | -14.10M | |
| Cash from Investing | -246.11M | 40.58M | -15.95M | -18.67M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 2.34M | 13.83M | 6.73M | 5.54M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 0.00 | -11.00K | |
| Cash from Financing | 2.34M | 13.83M | 6.73M | 5.53M | |
| Foreign Exchange rate Adjustments | 56.00K | 1.76M | -1.44M | 880.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -156.90M | 88.75M | 55.31M | 29.39M | |